Acitretin combination therapy - 07/09/11
Abstract |
Systemic therapies used in psoriasis such as methotrexate, PUVA, cyclosporine, and acitretin often have side effects that limit their usefulness. Combination therapy, an effective strategy for treating psoriasis, allows use of lower doses of medications to achieve superior therapeutic results with fewer side effects. Acitretin is one of the most popular drugs used in combination with other systemic therapies for psoriasis. Details of the regimens used and results obtained from combining acitretin with PUVA, cyclosporine, and methotrexate are discussed. (J Am Acad Dermatol 1999;41:S18-21.)
Le texte complet de cet article est disponible en PDF.Plan
 | From Arizona Advanced Dermatology, Phoenix, and Northwestern University Medical School, Chicago. |
| This manuscript is based on a presentation given at the 5th European Congress on Psoriasis/7th International Psoriasis Symposium in Milan, Italy on September 2, 1998, with support from Roche Laboratories, Inc., Nutley, NJ. |
 | Reprint requests: Henry H. Roenigk, Jr, MD, Arizona Advanced Dermatology, 500 W Thomas Road, Suite 360, Phoenix, AZ 85013. |
| 0190-9622/99/$8.00 + 0 16/0/100480 |
Vol 41 - N° 3S
P. S18-S21 - septembre 1999 Retour au numéro
Article précédent
- Acitretin: Optimal dosing strategies
- Mark R. Ling
- Acitretin in combination with UVB or PUVA
- Mark Lebwohl
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?